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ABSTRACT
Objectives: To assess the comparability, reliability, and sub-
ject acceptability  of  electronic  data  capture  (EDC)  versions
of Irritable Bowel Syndrome—Quality of Life (IBS-QOL),
EuroQoL (EQ-5D) and Work Productivity and Activity
Impairment (WPAI:IBS) instruments.
Methods: Comparability of EDC and paper questionnaires
was evaluated in 72 subjects with IBS who completed a base-
line EDC or paper questionnaire, a crossover questionnaire
24 hours later, and a retest of the crossover version at
1 week. The EDC version was presented on a hand-held
device. Comparability was assessed using paired t-test statis-
tics, intraclass correlation coefﬁcients (ICC) and tests for
internal consistency (Cronbach’s alpha).
Results: No signiﬁcant differences were found between
scores obtained by paper questionnaire and EDC at the base-
line and crossover assessments. ICCs between baseline and
crossover assessments ranged from 0.83 to 0.96 for the IBS-
QOL scores, 0.82 to 0.96 for the WPAI:IBS scores, and 0.77
to 0.82 for the EQ-5D. Internal consistency was comparable
for the two data collection methods for the IBS-QOL overall
score (0.96) and subscales and the EQ-5D Index (0.70 vs.
0.74). Retest statistics (ICC) were generally comparable
between the EDC and paper versions for all scores. Ease of
use was comparable for the two modes of administration,
but more patients preferred EDC (47.2%) than the paper
questionnaire (23.6%).
Conclusions: EDC versions of the IBS-QOL, EQ-5D, and
WPAI:IBS are comparable to paper questionnaires in internal
consistency and test–retest reliability, and have greater
patient acceptability.
Keywords: electronic data capture, EQ-5D, EuroQoL, IBS-
QOL, irritable bowel syndrome, quality of life, work pro-
ductivity, WPAI:IBS.
Background
Patient-reported outcomes in clinical studies have gen-
erally been obtained by self-administered paper ques-
tionnaires. Electronic data capture (EDC) with hand-
held or desktop computers is an alternative mode of
data collection that offers many potential beneﬁts over
paper questionnaires, including customization of ques-
tions depending on a prior response, automatic date
and time stamping, and immediate data entry that
eliminates the possibility of subsequent entry errors.
Several recent studies have found that patient-reported
outcome data collected with EDC are psychometrically
comparable to data collected by the standard paper
mode, in terms of validity and reliability, and that EDC
has high acceptance, and is generally preferred over the
paper mode by the majority of subjects [1–6].
The validity and acceptability of EDC in studies of
patients with irritable bowel syndrome (IBS) have not
been investigated. Questionnaires useful for assessing
outcomes in IBS studies include validated disease-spe-
ciﬁc quality of life and work productivity question-
naires, as well as general health questionnaires or
utility measures for valuing IBS decrements relative to
other diseases. The IBS Quality of Life Questionnaire
(IBS-QOL) is an IBS-speciﬁc measure with established
internal consistency, test–retest reliability and validity
[7,8]. The Work Productivity and Activity Impairment
Questionnaire has been validated for IBS (WPAI:IBS)
[9], as well as for other diseases, such as allergies [10],
gastroesophageal reﬂux disease [11], and chronic hand
dermatitis [12]. The validity and reliability of the
EuroQol (EQ-5D) [13], a general health measure, has
been established in several diseases, including inﬂam-
matory bowel disease [14], rheumatoid arthritis [15],
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AIDS [16], and IBS [17]. The objectives of this study
were to test the equivalence of the EDC versions of the
IBS-QOL, WPAI:IBS and EQ-5D with the paper ver-
sions of these questionnaires in IBS patients, and to
assess respondent acceptability of the EDC format to
determine whether EDC would be a valid and appro-
priate methodology for obtaining patient-reported
outcomes in IBS studies.
Methods
Subject Enrollment and Study Design
This was a randomized crossover study designed to
test the effect of mode of questionnaire administration
(paper vs. EDC) on patient-reported outcomes. The
study was conducted between May and July 2004, at
two US sites (Seattle, Washington and Rockford, Illi-
nois) with recruitment through general advertisement.
Patients aged 18 years or above who met Rome II diag-
nostic criteria for IBS [18] and signed informed
consent were eligible to participate. Patients were
randomized in equal numbers to the two sequences of
questionnaire administration; efforts were made to
recruit patients who were diverse as to sex and type of
IBS (constipation predominant, diarrhea predominant,
and alternating). The study consisted of the comple-
tion of a baseline questionnaire (paper or EDC), a
crossover questionnaire within 24 hours, and a retest
of the crossover questionnaire 7 days later, that is, a
sequence of either paper-EDC-EDC or EDC-paper-
paper (see Fig. 1).
A hand-held electronic device with entry by stylus
was used for EDC. One question was displayed per
screen and once a response was entered the next item
automatically appeared. Subjects were not allowed to
skip questions, and there was an option to return to
review or change a previous question. There were
minor formatting differences between the paper ques-
tionnaire and EDC, for example, in fonts and bolding,
but the questions themselves were identical in both
presentations. All paper questionnaires and EDC were
completed at the study site (research facility in Seattle
and clinical setting in Rockford).
Additional information was obtained by paper
questionnaire throughout the course of the study.
Before randomization, all qualiﬁed patients completed
questions about demographics, IBS characteristics and
other health information. Following administration of
the baseline and crossover questionnaires patients
completed questions about the acceptability of the
administration mode just completed, and at the cross-
over assessment, questions about preferences for the
mode of administration. At baseline, symptom sever-
ity was rated and at the retest visit, patients completed
a question assessing the global rating of change in
overall quality of life. All patients enrolled completed
the study. Patients were compensated for their
participation.
Outcomes Questionnaires
The IBS-QOL is a 34-item condition-speciﬁc instru-
ment that assesses overall quality of life and eight
domains (dysphoria, interference with activity, body
image, health worry, food avoidance, social reactions,
relationships, and sexual). Each item has a ﬁve-point
Likert response scale that assesses how much the item
describes the respondent during the past month (not at
all, slightly, moderately, quite a bit, and extremely or a
great deal). Items scores are summed to derive the
overall score and eight subscales; scores are trans-
formed to a 0- to 100-scale ranging from 0 (poor qual-
ity of life) to 100 (maximum quality of life).
The WPAI:IBS asks questions about the effect of
IBS symptoms, for example, abdominal discomfort,
abdominal pain, bloating, constipation, and diarrhea
on ability to work and perform regular daily activi-
ties during the past 7 days. It consists of six items:
employment status; hours missed resulting from IBS;
hours missed for other reasons; hours worked; lost
work productivity and daily activity impairment
resulting from IBS. Four scores are calculated: absen-
teeism (work time missed), presenteeism (impair-
ment while at work), overall work productivity loss
(absenteeism + presenteeism), and daily activity
impairment. Scores are expressed as percentages,
with higher scores indicating more productivity loss.
The EQ-5D consists of a ﬁve-item descriptive
system and the EQ Visual Analog Scale (VAS). The
descriptive system records the level of self-reported
problems on each of the dimensions of the classiﬁca-
tion (mobility, self-care, usual activities, pain/discom-
fort, anxiety/depression) on the day the questionnaire
is completed. Health states deﬁned by the descriptive
system can be converted into a weighted health state
index by applying scores elicited from general popula-
tion samples. Respondents describe their own healthFigure 1 Study design. EDC, electronic data capture.
Baseline paper Baseline EDC 
Crossover paper Crossover EDC 
Retest paper Retest EDC 
24 hours 
 keew 1 keew 1
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status that day using a 20-cm VAS, ranging from 0,
worst imaginable health state, to 100, best imaginable
health state.
Additional Measures
The Short Form 36-Item Health Survey (SF-36) [19] is
a generic measure of functional status and well-being.
It contains 36 questions that measure health across
eight dimensions and two summary measures: the
physical component (PCS) and the mental component
(MCS). Scores within a dimension are reported on a
scale from 0 to 100, where higher scores indicate
“good health” and 0 indicates “poor health.” Items
with a recall period refer to the last 4 weeks.
Respondent acceptability of the two modes of
administration was assessed with questions regarding
ease of reading, ease in changing response and difﬁ-
culty using the two formats. Responses were scored on
10-cm VAS, from 0, not at all easy (difﬁcult) to 100,
extremely easy (difﬁcult). Preference for administra-
tion mode was assessed by asking which method was
easier to use and which method was preferred. Severity
of IBS symptoms during the past 7 days was assessed
using a 0- to 10-point numerical scale ranging from no
symptoms (0) to very severe symptoms (10). At the
ﬁnal retest visit, patients rated the global change in
their overall quality of life as “A lot better,” “Some-
what better,” “About the same,” “Somewhat worse,”
or “A lot worse.”
Statistical Methods
Comparability of the two modes of administration was
evaluated by testing differences in scores between the
baseline and 24-hour crossover assessments with Stu-
dent’s t-test and the intraclass correlation coefﬁcient
(ICC). The ICC is the preferred measure of strength of
association for determining stability of scores over
time because it corrects for lack of independence
between measurement intervals [20]. The ICC ranges
between 0.00 and 1.00, and the minimal acceptable
level is 0.70 [21].
Cronbach’s alpha was used to determine whether
the items within the scaled questionnaires had the
same degree of association in the two modes of admin-
istration at the baseline assessment. A minimum cor-
relation of 0.70 is necessary to support internal
consistency and alpha values between 0.85 and 0.95
are preferred [22]. An alpha value of 0.95 has been
previously reported for the IBS-QOL total score [7].
Internal reliability does not apply to the WPAI:IBS or
EQ-5D because these scores are single items.
Test–retest reliability was assessed using the ICC to
compare the relationship between the crossover assess-
ment and the retest assessment for the two modes of
administration. The test–retest analysis was restricted
to subjects rating their overall quality of life “about the
same” on the global rating of change item at the retest
visit. Previously reported ICC values for the IBS-QOL
total score was 0.86 [7].
For each mode of administration, the relationship
between IBS-QOL, EQ-5D, and WPAI:IBS component
scores and the physical and mental summary scores of
the SF-36 was assessed using Pearson correlation coef-
ﬁcients, and the magnitude of the coefﬁcients was com-
pared across mode of administration. Discriminant
validity of the scores from the two modes of adminis-
tration (pooled from baseline and crossover for paper
and for EDC) was compared relative to IBS symptom
severity. An examination of responses to the symptom
severity question indicated that they could be catego-
rized as low (0–5), middle (6–7) or high (8–10) to
permit a sufﬁcient sample size in each category. Differ-
ences in mean scores between severity categories were
tested with analysis of variance (ANOVA).
Acceptability of the two modes of administration
was evaluated with descriptive statistics. Differences in
the ease of using the two modes, as reported by the
participants, were assessed with Student’s paired t-test.
Results for work productivity scores apply only to
employed patients and are limited by the small sample
size. All analyses were conducted using SPSS [23]. A P-
value <0.05 was required for signiﬁcance using two-
sided hypothesis tests; no P-value adjustments were
made for the analysis of multiple endpoints.
Results
Table 1 shows the characteristics of the population by
initial mode of questionnaire administration. Patients
had a mean age of 46.2 years and were predominately
female (86.1%); 69.4% were currently employed. All
IBS types were represented: 25% of patients had IBS
with constipation, 33.3% had IBS with diarrhea, and
41.7% had alternating IBS. Compared with patients
randomized to the paper-ﬁrst group, the EDC-ﬁrst
group tended to be younger (42.4 vs. 48.5 years),
female (91.4% vs. 81.1%), and less likely to have a
college degree (18.9% vs. 34.3%). The EDC-ﬁrst
group was more likely to have IBS with diarrhea (40%
vs. 27%) and have a shorter IBS duration (13.0 vs.
16.9 years). Employment rates were comparable.
Table 2 shows the mean scores for the baseline and
crossover assessments by mode of initial questionnaire
administration. There were no signiﬁcant differences
between the baseline and crossover scores for subjects
in either administration group. ICC statistics were
above 0.70 for each IBS-QOL, EQ-5D, and WPAI
measure for both sequences of administration.
Table 3 shows the results of the internal consistency
evaluation of the IBS-QOL and the EQ-5D Index at
baseline and test–retest reliability of these two meas-
ures and the EQ-5D VAS and WPAI:IBS. Internal
consistency was comparable for both modes of
administration of the IBS-QOL and the EQ-5D; both
Validation of Electronic Data Capture for IBS 101
Table 1 Characteristics of the population by mode of initial administration
Characteristic
Mean (±SD) or percentage initial administration
EDC (n = 37) Paper (n = 35) Total (n = 72)
Age (years) 42.4 (13.7) 48.5 (14.2) 46.2 (13.5)
[range] [21.–72] [21–83] [21–83]
F = 1.931 (P = 0.16909)
Sex (female, %) 81.1 91.4 86.1
χ2 = 1.610 (P = 0.20446)
Highest level of school (%)
High school graduate or less 21.6 28.6 25.0
Some college/2-year degree 59.5 37.1 48.6
4-year college graduate 18.9 34.3 26.4
χ2 = 3.435 (P = 0.32933)
Length of time with IBS symptoms (years) 13.0 (9.5) 16.9 (15.2) 14.8 (12.6)
F = 1.799 (P = 0.18423)
Type of IBS (%)
Constipation 20.0 29.7 25.0
Diarrhea 40.0 27.0 33.3
Alternating 40.0 43.2 41.7
χ2 = 1.635 (P = 0.44162)
Currently employed (%) 70.3 68.6 69.4
χ2 = 0.008 (P = 0.92725)
EDC, electronic data capture; IBS, irritable bowel syndrome.





Baseline paper questionnaire and 24-hour crossover electronic data capture (EDC) (n = 35)
IBS-QOL
Overall 69.3 (18.4) 73.8 (17.6) 0.29 0.96
Dysphoria 71.0 (21.7) 76.9 (20.4) 0.24 0.91
Interference with activity 58.9 (24.9) 63.9 (24.4) 0.39 0.95
Body image 62.4 (22.0) 68.1 (19.9) 0.25 0.96
Health worry 71.2 (22.5) 76.0 (20.6) 0.34 0.83
Food avoidance 62.7 (24.3) 63.5 (23.1) 0.88 0.91
Social reactions 75.3 (21.9) 79.7 (19.7) 0.38 0.91
Sexual 81.9 (20.3) 84.9 (18.0) 0.51 0.93
Relationships 76.2 (21.7) 81.0 (21.5) 0.34 0.93
EQ-5D
VAS 75.8 (15.4) 75.1 (16.4) 0.85 0.77
Index 0.72 (0.25) 0.72 (0.24) 0.91 0.80
WPAI:IBS
Absenteeism (n = 23) 4.0 (9.3) 3.7 (7.7) 0.52 0.96
Presenteeism (n = 23) 27.4 (23.0) 22.6 (20.9) 0.15 0.84
Work productivity loss (n = 23) 31.4 (28.0) 26.3 (20.9) 0.56 0.90
Daily activity impairment (n = 35) 33.7 (25.0) 29.7 (24.0) 0.18 0.87
Baseline electronic data capture (EDC) and 24-hour crossover paper questionnaire (n = 37)
IBS-QOL
Overall 66.1 (20.5) 63.5 (21.0) 0.60 0.96
Dysphoria 66.7 (25.3) 62.9 (26.6) 0.54 0.95
Interference with activity 60.4 (29.2) 56.4 (30.2) 0.57 0.91
Body image 63.8 (22.0) 60.6 (21.3) 0.53 0.93
Health worry 67.0 (25.9) 68.1 (25.9) 0.87 0.91
Food avoidance 58.5 (29.1) 54.9 (29.4) 0.60 0.94
Social reactions 69.3 (26.1) 69.3 (24.1) 1.00 0.91
Sexual 72.5 (22.8) 72.7 (23.5) 0.97 0.93
Relationships 75.0 (22.8) 71.8 (22.5) 0.55 0.90
EQ-5D
VAS 70.8 (21.0) 64.0 (24.5) 0.21 0.82
Index 0.71 (0.23) 0.63 (0.28) 0.16 0.77
WPAI:IBS
Absenteeism (n = 25) 3.3 (6.4) 3.4 (7.5) 0.78 0.94
Presenteeism (n = 25) 30.4 (21.5) 33.6 (23.6) 0.34 0.85
Work productivity loss (n = 25) 33.7 (24.7) 37.0 (28.2) 0.32 0.90
Daily activity impairment (n = 25) 40.5 (25.7) 42.0 (23.9) 0.67 0.82
*Student’s t-test.
IBS-QOL, Irritable Bowel Syndrome—Quality of Life; VAS, Visual Analog Scale; WPAI:IBS, Work Productivity and Activity Impairment questionnaire—Irritable Bowel Syndrome
version.
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questionnaires and modes of administration demon-
strated internal consistency with alpha values all above
0.70, with the exception of the Relationship domain of
the IBS-QOL EDC which was 0.69. Among stable sub-
jects, retest statistics (ICC) were comparable between
the EDC and paper versions of the IBS-QOL, with all
correlations above 0.88, and for the EDC and paper
versions of the EQ-5D, with all correlations above
0.73. The analysis of the reliability of the WPAI:IBS
was limited by the small sample of stable employed
patients in the paper and EDC groups (n = 15 and 13,
respectively). Nevertheless, all correlations were above
0.75, except for absenteeism, which was 0.68.
Table 4 shows the correlation coefﬁcients between
the IBS-QOL, EQ-5D, and WPAI:IBS component
scores and the SF-36 physical and mental summary
scores. The correlation coefﬁcients were generally
comparable for the two modes of administration.
Table 5 shows the mean IBS-QOL, WPAI:IBS, and EQ-
5D scores for the two modes of administration (pooled
baseline and crossover) by level of disease severity. For
the paper version, there were signiﬁcant differences for
Table 3 Internal consistency and test–retest reliability of the questionnaires by mode of administration
Internal consistency* Test–retest reliability†
Paper (n = 35) EDC (n = 37) Paper (vs. paper) (n = 20) EDC (vs. EDC) (n = 20)
IBS-QOL
Overall 0.96 0.96 0.99 0.95
Dysphoria 0.94 0.95 0.99 0.93
Interference with activity 0.82 0.89 0.93 0.96
Body image 0.79 0.72 0.93 0.95
Health worry 0.74 0.79 0.94 0.88
Food avoidance 0.83 0.88 0.95 0.90
Social reactions 0.84 0.80 0.91 0.90
Sexual 0.75 0.77 0.92 0.94
Relationships 0.77 0.69 0.94 0.92
EQ-5D Index 0.74 0.70 0.77 0.75
EQ-5D VAS NA NA 0.82 0.73
WPAI:IBS
Absenteeism NA NA 0.68 (n = 15) 0.93 (n = 13)
Presenteeism NA NA 0.75 (n = 15) 0.97 (n = 13)
Work productivity loss NA NA 0.84 (n = 15) 0.98 (n = 13)
Daily activity impairment NA NA 0.90 (n = 20) 0.83 (n = 20)
*As measured by Cronbach’s alpha using baseline administration.
†As measured by the intraclass correlation coefﬁcient using the crossover and retest assessment at 1 week. Includes only those patients reporting no change on the global rating
of change at the 1-week retest.
EDC, electronic data capture; NA, not applicable; VAS, Visual Analog Scale; WPAI:IBS, Work Productivity and Activity Impairment questionnaire—Irritable Bowel Syndrome
version.
Table 4 Correlation between IBS-QOL, EQ-5D, and WPAI:IBS and SF-36 summary scores by mode of administration
SF-36 physical component summary SF-36 mental component summary
Paper (n = 72) EDC (n = 72) Paper (n = 72) EDC (n = 72)
IBS-QOL
Overall 0.40 (0.00058) 0.36 (0.00207) 0.47 (0.00003) 0.46 (0.00005)
Dysphoria 0.49 (0.00002) 0.45 (0.00008) 0.51 (0.00000) 0.50 (0.00000)
Interference with activity 0.36 (0.00225) 0.30 (0.01039) 0.37 (0.00133) 0.40 (0.00054)
Body image 0.21 (0.07984) 0.23 (0.05312) 0.32 (0.00594) 0.34 (0.00306)
Health worry 0.32 (0.00646) 0.35 (0.00234) 0.43 (0.00016) 0.44 (0.00012)
Food avoidance 0.33 (0.00455) 0.24 (0.04316) 0.34 (0.00387) 0.34 (0.00370)
Social reaction 0.19 (0.10465) 0.17 (0.16435) 0.29 (0.01219) 0.33 (0.00482)
Sexual 0.22 (0.06297) 0.19 (0.10924) 0.32 (0.00709) 0.24 (0.04495)
Relationships 0.22 (0.06948) 0.26 (0.02916) 0.31 (0.00914) 0.27 (0.02193)
EQ-5D
VAS 0.55 (0.00000) 0.60 (0.00000) 0.54 (0.00000) 0.45 (0.00007)
Index 0.63 (0.00000) 0.60 (0.00000) 0.32 (0.00582) 0.47 (0.00004)
WPAI:IBS
Absenteeism† 0.04 (0.79057) 0.07 (0.64161) −0.33 (0.02246) −0.41 (0.00374)
Presenteeism‡ −0.33 (0.01954) −0.22 (0.13021) −0.35 (0.01425) −0.46 (0.00113)
Work productivity loss† −0.24 (0.09970) −0.17 (0.25854) −0.39 (0.00614) −0.49 (0.00035)
Daily activity impairment −0.60 (0.00000) −0.43 (0.00015) −0.34 (0.00351) −0.40 (0.00049)
†n = 49 paper, n = 48 EDC.
‡n = 50 paper, n = 48 EDC.
EDC, electronic data capture; IBS-QOL, Irritable Bowel Syndrome—Quality of Life; VAS, Visual Analog Scale; WPAI:IBS, Work Productivity and Activity Impairment question-
naire—Irritable Bowel Syndrome version.
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all measures by severity category (P-values 0.03 to
<0.0001), with higher severity scores associated with
higher impairment. Each of the summary scores were
markedly different at each level of symptom severity,
with the exception of the EQ-5D Index which had
comparable scores for the low and middle severity
groups (0.78 and 0.75). For EDC, there were signiﬁ-
cant differences by level of severity for the IBS-QOL
overall score (P < 0.002) and the WPAI:IBS activity
impairment score (P < 0.0001). Again, the EQ-5D
Index scores did not differentiate the low and middle
symptom severity groups (0.70 for both). Although the
trend for the WPAI:IBS overall work productivity loss
score indicated that higher symptom severity was asso-
ciated with higher impairment (21.2%, 37.2%, and
40.5% for the low, middle, and high severity groups,
respectively), the differences were not signiﬁcant.
Table 6 shows ease of use for the two modes of
administration by initial mode of administration. Both
versions were rated easy to read, regardless of which
mode was administered ﬁrst, with mean scores ranging
from 87.9 to 91.8 out of a possible high score of 100.
Patients reported it was signiﬁcantly easier to go back
and change answers on the EDC version than in the
paper version, regardless of whether paper or EDC
was administered ﬁrst (P-values 0.004 and 0.001), but
there were no signiﬁcant differences in difﬁculty using
the two administration modes.
Table 7 shows the preference for the two modes
of administration. Overall, 47.2% of the patients
thought the EDC version was easier to use; 23.6%
thought the paper questionnaire was easier to use
and 29.2% thought there was no difference between
methods. If the patients were to participate in
Table 5 IBS-QOL, EQ-5D, and WPAI:IBS summary scores by symptom severity and mode of questionnaire administration
IBS symptom severity Overall IBS-QOL EQ-5D VAS Overall work productivity loss Activity Impairment
Paper administration (pooled baseline and crossover)
Low (0–5)
Mean 77.0 0.78 19.9 21.7
N 24 24 18 24
Middle (6–7)
Mean 67.3 0.75 39.6 40.9
N 32 32 21 32
High (8–10)
Mean 54.5 0.55 41.5 53.1
N 16 16 10 16
Total
Mean 67.7 0.72 32.7 37.2
N 72 72 49 72
P-value P = 0.00096 P = 0.00590 P = 0.02533 P = 0.00015
EDC administration (pooled baseline and crossover)
Low (0–5)
Mean 78.5 0.70 21.2 21.7
N 24 24 18 24
Middle (6–7)
Mean 67.5 0.70 37.2 38.8
N 32 32 20 32
High (8–10)
Mean 56.3 0.58 40.5 51.9
N 16 16 10 16
Total
Mean 68.7 0.67 31.9 36.0
N 72 72 48 72
P-value P = 0.00156 P = 0.28841 P = 0.10140 P = 0.00026
EDC, electronic data capture; IBS-QOL, Irritable Bowel Syndrome—Quality of Life; VAS, Visual Analog Scale; WPAI:IBS, Work Productivity and Activity Impairment question-
naire—Irritable Bowel Syndrome version.
Table 6 Ease of using the paper questionnaire and electronic data capture (EDC) by mode of ﬁrst administration
Paper ﬁrst mean (±SD) 
[Range] n = 35
EDC ﬁrst mean (±SD) 
[Range] n = 37
Paper EDC Paper EDC
How easy was the diary to read 90.7 (8.1) 87.9 (17.1) 91.8 (11.8) 91.2 (11.3)
Not at all easy (0) to extremely easy (100) [72–100] [26–100] [47–100] [47–100]
How easy was it to go back and change answers? 77.9 (26.6)* 92.3 (9.1) 73.1 (35.8)* 93.5 (14.8)
Not at all easy (0) to extremely easy (100) [10–100] [64–100] [0–100] [9–100]
How difﬁcult was it to use this diary? 10.1 (19.5) 9.1 (18.2) 13.5 (26.2) 5.9 (10.4)
Not at all difﬁcult (0) to extremely difﬁcult (100) [0–82] [0–94] [0–100] [0–47]
*P  ≤ 0.004 by Student’s paired t-test.
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another study, half would prefer EDC, 13.9% would
prefer paper questionnaires, and 36.1% would have
no preference. No missing data were found in either
mode of administration.
Discussion
Electronic data capture is increasingly being used to
collect patient-reported outcomes data in clinical stud-
ies. We tested three previously validated questionnaires
(IBS-QOL, WPAI:IBS, EQ-5D) to determine whether
the EDC versions of these questionnaires were compa-
rable to the paper versions and acceptable to subjects,
and therefore suitable for use in IBS studies.
We found no signiﬁcant differences between the
scores obtained by paper questionnaire and EDC and
no pattern of results emerged that would suggest that
one mode of administration was better than the other
in terms of its psychometric properties. Scores from
both modes of administration had comparable corre-
lations with SF-36 measures of physical and mental
well-being. Scores obtained by both paper question-
naire and EDC demonstrated internal consistency,
test–retest reliability, and validity, as measured by the
relationship of scores to symptom severity. The one
exception was the EQ-5D VAS that did not differenti-
ate the low and middle symptom severity groups in
either mode of administration. This is not surprising
considering that this is a general health measure for a
single day and the criterion for discriminant validity
was IBS symptom severity for the past 7 days. Accept-
ability of both modes of administration was high, but
patients reported the EDC mode was signiﬁcantly eas-
ier for going back and changing a response, and more
patients preferred EDC over the paper questionnaire.
Our subjects were selected to be representative of
IBS patients in terms of sex and type of IBS, but our
results are limited by the small sample size, particularly
among the employed (n = 49) in the investigation of
WPAI:IBS work productivity measures. Consequently,
although we failed to demonstrate statistically signiﬁ-
cant differences between the two modes of administra-
tion, there may be differences that we were unable to
detect. For example, we note that impairment as meas-
ured by the IBS-QOL and WPAI:IBS domain scores
uniformly decreased from baseline to the 24-hour
crossover assessment, regardless of mode of adminis-
tration, whereas the EQ-5D scores were generally
higher when obtained by paper questionnaire, regard-
less of whether paper was administered ﬁrst or second.
Investigation of these differences was outside the scope
of the planned analysis and warrant additional
investigation.
Another limitation of our ﬁndings is that they may
not reﬂect the application of the two modes of admin-
istration in the typical clinical setting, in terms of miss-
ing information. Because subjects could not skip an
entry in EDC and the site coordinators rigorously
reviewed completed paper questionnaires and
retrieved missing information from subjects, missing
information was not found in either mode of admin-
istration. In other settings, paper questionnaires have
had higher rates of missing information relative to
EDC [24–26], so the advantage of EDC in this study
may be understated.
Despite the study’s limitations, the ﬁndings of com-
parability between the two modes of administration
are consistent with a growing body of research in a
variety of diseases, populations, and settings that has
shown EDC to be comparable to paper questionnaires.
Conclusion
Electronic Data Capture versions of the IBS-QOL, EQ-
5D, and WPAI:IBS are generally comparable to paper
questionnaires and demonstrate internal consistency,
test–retest reliability, and subject acceptability; discri-
minant validity of the questionnaires by the two modes
of administration is comparable.
Source of ﬁnancial support: Novartis Pharma AG, Basel,
Switzerland.
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